
|
|
CFO Comment on EBA EU-Wide Stress Test
"Our result of 13.4% fully loaded CET1 in the EBA's hypothetical adverse scenario demonstrates our high capital base and capital resilience in the EBA adverse scenario. Capital depletion of 2.98% marks a significant improvement on the 2023 exercise. AIB continues to be very well-capitalised with a CET1 ratio of 16.4%(1) at H1 2025 which remains substantially in excess of regulatory requirements."
Results of EBA EU-Wide Stress Test
AIB was subject to the 2025 EU‐wide stress test conducted by the EBA, in cooperation with the
AIB's capital ratios and EBA stress test results are outlined below:
|
|
CET1 actual |
15.11% |
CET 1 restated CRR3* |
16.38% |
EBA 2025 stress test results |
|
CET 1 |
13.40% |
*Restated CET1 following Basel IV implementation on
The 2025 EBA stress test adverse scenario resulted in capital depletion of 2.98% on a fully loaded basis and is lower than the 2023 EBA stress test adverse scenario (capital depletion 6.32%) largely as a result of increased net interest income due to the recent higher rate environment.
CET1 in the adverse scenario of 13.4% is well above total SREP capital requirements (TSCR) of 5.85%(2).
The 2025 EU-wide stress test does not contain a pass-fail threshold and instead is designed to assist competent authorities in assessing AIB's ability to meet applicable prudential requirements under stressed scenarios.
The adverse stress test scenario was set by the
To view the results including disclosure templates published by EBA for AIB, please click here
(1) The CET1 ratio of 16.4% does not include interim profits for the half-year 2025 pending a final decision on payout at year end
(2) TSCR is the sum of Pillar 1 (4.5%) and Pillar 2 requirement (1.35%) and excludes combined buffer requirements
-ENDS-
For further information, please contact:
Group Investor Relations Tel: + 353 86 313 5647
|
Investor Relations Tel: + 353 87 3956864
|
Tel: +353 86 8502204
|
Forward Looking Statements
This document contains certain forward looking statements with respect to the financial condition, results of operations and business of
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the